These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 33433203)

  • 1. Spherical Nucleic Acids for Topical Treatment of Hyperpigmentation.
    Fang Y; Lu X; Wang D; Cai J; Wang Y; Chen P; Ren M; Lu H; Union J; Zhang L; Sun Y; Jia F; Kang X; Tan X; Zhang K
    J Am Chem Soc; 2021 Jan; 143(3):1296-1300. PubMed ID: 33433203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 4-n-butylresorcinol, a highly effective tyrosinase inhibitor for the topical treatment of hyperpigmentation.
    Kolbe L; Mann T; Gerwat W; Batzer J; Ahlheit S; Scherner C; Wenck H; Stäb F
    J Eur Acad Dermatol Venereol; 2013 Jan; 27 Suppl 1():19-23. PubMed ID: 23205541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salidroside can target both P4HB-mediated inflammation and melanogenesis of the skin.
    Ding XJ; Zhang ZY; Jin J; Han JX; Wang Y; Yang K; Yang YY; Wang HQ; Dai XT; Yao C; Sun T; Zhu CB; Liu HJ
    Theranostics; 2020; 10(24):11110-11126. PubMed ID: 33042273
    [No Abstract]   [Full Text] [Related]  

  • 4. Anti-Pigmentation Effects of Eight
    Ahn HY; Choo YM; Cho YS
    J Microbiol Biotechnol; 2018 Mar; 28(3):375-380. PubMed ID: 29316744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical efficacy and safety of 4-hexyl-1,3-phenylenediol for improving skin hyperpigmentation.
    Won YK; Loy CJ; Randhawa M; Southall MD
    Arch Dermatol Res; 2014 Jul; 306(5):455-65. PubMed ID: 24402285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting tyrosinase in hyperpigmentation: Current status, limitations and future promises.
    Zolghadri S; Beygi M; Mohammad TF; Alijanianzadeh M; Pillaiyar T; Garcia-Molina P; Garcia-Canovas F; Munoz-Munoz J; Saboury AA
    Biochem Pharmacol; 2023 Jun; 212():115574. PubMed ID: 37127249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Standardized Extract of Juniperus communis Alleviates Hyperpigmentation in Vivo HRM-2 Hairless Mice and in Vitro Murine B16 Melanoma Cells.
    Jegal J; Chung KW; Chung HY; Jeong EJ; Yang MH
    Biol Pharm Bull; 2017; 40(9):1381-1388. PubMed ID: 28867722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-melanogenic effects of Aster spathulifolius extract in UVB-exposed C57BL/6J mice and B16F10 melanoma cells through the regulation of MAPK/ERK and AKT/GSK3β signalling.
    Hwang GY; Choung SY
    J Pharm Pharmacol; 2016 Apr; 68(4):503-13. PubMed ID: 26993057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of Human Tyrosinase Requires Molecular Motifs Distinctively Different from Mushroom Tyrosinase.
    Mann T; Gerwat W; Batzer J; Eggers K; Scherner C; Wenck H; Stäb F; Hearing VJ; Röhm KH; Kolbe L
    J Invest Dermatol; 2018 Jul; 138(7):1601-1608. PubMed ID: 29427586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo studies disclosed the depigmenting effects of gallic acid: a novel skin lightening agent for hyperpigmentary skin diseases.
    Kumar KJ; Vani MG; Wang SY; Liao JW; Hsu LS; Yang HL; Hseu YC
    Biofactors; 2013; 39(3):259-70. PubMed ID: 23322673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effects of salidroside and paeonol on tyrosinase activity and melanin synthesis in mouse B16F10 melanoma cells and ultraviolet B-induced pigmentation in guinea pig skin.
    Peng LH; Liu S; Xu SY; Chen L; Shan YH; Wei W; Liang WQ; Gao JQ
    Phytomedicine; 2013 Sep; 20(12):1082-7. PubMed ID: 23746955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thiamidol containing treatment regimens in facial hyperpigmentation: An international multi-centre approach consisting of a double-blind, controlled, split-face study and of an open-label, real-world study.
    Philipp-Dormston WG; Vila Echagüe A; Pérez Damonte SH; Riedel J; Filbry A; Warnke K; Lofrano C; Roggenkamp D; Nippel G
    Int J Cosmet Sci; 2020 Aug; 42(4):377-387. PubMed ID: 32390164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conjugation with Dihydrolipoic Acid Imparts Caffeic Acid Ester Potent Inhibitory Effect on Dopa Oxidase Activity of Human Tyrosinase.
    Micillo R; Sirés-Campos J; García-Borrón JC; Panzella L; Napolitano A; Olivares C
    Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30042336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Linoleic acid and alpha-linolenic acid lightens ultraviolet-induced hyperpigmentation of the skin.
    Ando H; Ryu A; Hashimoto A; Oka M; Ichihashi M
    Arch Dermatol Res; 1998 Jul; 290(7):375-81. PubMed ID: 9749992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural Tyrosinase Inhibitors: Role of Herbals in the Treatment of Hyperpigmentary Disorders.
    Zaidi KU; Ali SA; Ali A; Naaz I
    Mini Rev Med Chem; 2019; 19(10):796-808. PubMed ID: 31244414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p44/42 MAPK signaling is a prime target activated by phenylethyl resorcinol in its anti-melanogenic action.
    Kang M; Park SH; Park SJ; Oh SW; Yoo JA; Kwon K; Kim J; Yu E; Cho JY; Lee J
    Phytomedicine; 2019 May; 58():152877. PubMed ID: 30849679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Amide Derivatives as Potent Tyrosinase Inhibitors; In-vitro, In-vivo Antimelanogenic Activity and Computational Studies.
    Ali A; Ashraf Z; Rafiq M; Kumar A; Jabeen F; Lee GJ; Nazir F; Ahmed M; Rhee M; Choi EH
    Med Chem; 2019; 15(7):715-728. PubMed ID: 30892163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sesamol Inhibited Melanogenesis by Regulating Melanin-Related Signal Transduction in B16F10 Cells.
    Wu PY; You YJ; Liu YJ; Hou CW; Wu CS; Wen KC; Lin CY; Chiang HM
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29642438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effects of 5-chloroacetyl-2-piperidino-1,3-selenazole, a novel selenium-containing compound, on skin melanin biosynthesis.
    Lee EH; Lim YJ; Ha SK; Kang TH; Koketsu M; Kang C; Kim SY; Park JH
    J Pharm Pharmacol; 2010 Mar; 62(3):352-9. PubMed ID: 20487219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical treatment of hyperpigmentation disorders.
    Rendon M; Horwitz S
    Ann Dermatol Venereol; 2012 Dec; 139 Suppl 4():S153-8. PubMed ID: 23522631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.